在经济评价中捕获患者价值
本研究基于荷兰Maasstad医院2020至2021年772例类风湿关节炎(RA)患者的真实队列,比较电子咨询与面对面咨询的成本效果,并将基于通用EQ-5D的增量成本效果比(ICER)与基于RA特异性量表RAID和HAQ-DI的ICER进行对比。作者认为疾病特异性患者报告结局量表能更全面地捕获患者相关领域,是经济评价中传统量表的有前景的替代选择。
核心结论
- RA特异性量表能捕获患者相关领域,并有机会改善对疾病影响的评估和治疗。
研究设计与样本
- 研究使用荷兰Maasstad医院2020至2021年的真实队列,共纳入772例类风湿关节炎(RA)患者。
- 研究评估电子咨询与面对面咨询的成本效果,并将基于通用EQ-5D的ICER与基于RA特异性量表RAID和HAQ-DI的ICER进行比较。
- 为比较不同量表的成本效果,通过估计的转换方程将HAQ-DI和RAID转换为质量调整生命年(QALY)。
主要发现
- 疾病特异性患者报告结局量表(PROMs)为经济评价中的传统量表提供了有前景的替代选择,能更全面地捕获患者相关领域。
- 由于PROMs在临床实践中应用日益增多,下一步需要对RA患者全范围的转换方程进行建模,以便在经济评价中实施PROMs。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Economic evaluations predominantly use generic outcomes, such as the Euro Quality of Life-5 Dimension (EQ-5D), to assess health status. However, because of the generic nature, they are less suitable to capture the quality of life of patients with specific conditions. Given the transition to patient-centered (remote) care delivery, this study aims to evaluate the possibility of using disease-specific measures in a cost-effectiveness analysis. METHODS: A real-life cohort from Maasstad Hospital (2020-2021) in the Netherlands, with 772 patients with rheumatoid arthritis (RA), was used to assess the cost-effectiveness of electronic consultations (e-consultations) compared with face-to-face consultations. The Incremental Cost-Effectiveness Ratio (ICER), based on the generic EQ-5D, was compared with ICER's based on RA-specific measures: the Rheumatoid Arthritis Impact of Disease (RAID) and Health Assessment Questionnaire-Disability Index (HAQ-DI). To compare the cost-effectiveness of these different measures, HAQ-DI and RAID were expressed in quality-adjusted life-years (QALYs) via estimated conversion equations. RESULTS: Disease-specific patient-reported outcome measures (PROMs) offer a promising alternative for traditional measures in economic evaluations, capturing patient-relevant domains more comprehensively. Because PROMs are increasingly applied in clinical practice, the next step entails modeling of an RA patient-wide conversion equation to implement PROMs in economic evaluations. CONCLUSION: The conventional ICER (eg, EQ-5D) indicates that e-consultations are cost-effective with cost savings of -€161,000 per QALY gained for a prevalent RA cohort treated in a secondary trainee hospital. RA-specific measures show similar results, with ICERs of -€163,000 per HAQ-DI (QALY) and -€223,000 per RAID (QALY) gained. RA-specific measures capture patient-relevant domains and offer the opportunity to improve the assessment and treatment of the disease impact.
引用
- Koster F, Kok MR, Lopes Barreto D, et al. Capturing Patient Value in an Economic Evaluation. Arthritis Care Res (Hoboken). 2023. PMID: 37667586. doi:10.1002/acr.25229
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。